Treatment of Hypertension With Two Exercise Intensities
Phase 3
Completed
- Conditions
- Hypertension
Public Access Defibrillation (PAD) Community Trial
Phase 3
Completed
- Conditions
- ArrhythmiaMyocardial InfarctionVentricular FibrillationDeath, Sudden, CardiacHeart ArrestHeart Diseases
Antiarrhythmic Effects of N-3 Fatty Acids
Phase 2
Completed
- Conditions
- ArrhythmiaHeart DiseasesTachycardia, VentricularVentricular Fibrillation
Fatty Acid Antiarrhythmia Trial (FAAT)
Phase 3
Completed
- Conditions
- Ventricular FibrillationTachycardia, VentricularArrhythmiaHeart Diseases
Magnetic Resonance Imaging to Detect Blood Vessel Inflammation in Patients Undergoing Peripheral Balloon Angioplasty
Phase 1
Completed
- Conditions
- AtherosclerosisPeripheral Vascular Disease
- First Posted Date
- 2000-02-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 20
- Registration Number
- NCT00004549
- Locations
- 🇺🇸
National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States
Study of Skin Tumors in Tuberous Sclerosis
Recruiting
- Conditions
- Tuberous Sclerosis
- First Posted Date
- 2000-01-21
- Last Posted Date
- 2025-05-16
- Target Recruit Count
- 400
- Registration Number
- NCT00001975
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
MRI Evaluation of Chest Pain
Phase 2
Completed
- Conditions
- Chest PainMyocardial InfarctionCoronary Disease
- First Posted Date
- 2000-01-19
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 360
- Registration Number
- NCT00001961
- Locations
- 🇺🇸
National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States
Studying the Effectiveness of Pacemaker Therapy in Children Who Have Thickened Heart Muscle
Phase 2
Completed
- Conditions
- Hypertrophic Cardiomyopathy
- First Posted Date
- 2000-01-19
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 50
- Registration Number
- NCT00001960
- Locations
- 🇺🇸
National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States
Combination Therapy of Severe Aplastic Anemia
- First Posted Date
- 2000-01-19
- Last Posted Date
- 2021-03-16
- Target Recruit Count
- 104
- Registration Number
- NCT00001964
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure
Phase 2
Terminated
- Conditions
- Aplastic AnemiaPure Red Cell AplasiaDiamond Blackfan Anemia
- Interventions
- First Posted Date
- 2000-01-19
- Last Posted Date
- 2021-07-09
- Target Recruit Count
- 100
- Registration Number
- NCT00001962
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath